Showing 421 - 440 results of 41,597 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 1.05s Refine Results
  1. 421
  2. 422

    Immunodepletion assays of S100A6 and S100A11. by Christian Melle (268657)

    Published 2008
    “…<p>Normalized ProteinChip® array profiles of metastatic tissue show that the peaks representing S100A6 (A, 10.162 kDa) or S100A11 (B, 12.009 kDa) were detectable in the negative controls but only with decreased intensity with the corresponding depleted probes. …”
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427

    Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

    Published 2014
    “…<p>U251 cells were transfected with the indicated construct (50 ng) with (A) or without (B) siRNAs (10pmol). …”
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432

    Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

    Published 2014
    “…<p>(A) Turnover rates, as measured by 5-HIAA:5-HT ratios, normalized to the values of vehicle-treated animals, for the following drugs: fluoxetine (FLX; chronic treatment with 10 mg/kg); chlordiazepoxide (CDZ; 0.02 mg/kg); clonazepam (CLZ; 0.05 mg/kg); diazepam (DZP; 1.25 mg/kg); buspirone (BUS; 50 mg/kg); ethanol (EtOH, 2.5%); dizocilpine (MK; 0.005 mg/kg); verapamil (VER; 5 mg/kg); WAY 100,635 (WAY; 0.03 mg/kg); and SB 224,289 (SB; 2.5 mg/kg). …”
  13. 433

    Dataset for: Blindfolding during wakefulness causes decrease in sleep slow wave activity by Eva Magdalena Korf (3835795)

    Published 2017
    “…Previous studies showed that increasing and diminishing specific motor behaviours produced corresponding changes in SWA in the respective motor cortical areas during subsequent SWS. Here, we tested whether this relationship can be generalized to the visual system, i.e., whether diminishing encoding of visual information likewise leads to a localized decrease in SWA over the visual cortex. …”
  14. 434

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  15. 435
  16. 436
  17. 437
  18. 438
  19. 439
  20. 440